These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8552392

  • 1. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
    Srinivasan R, Maxwell SA.
    Oncogene; 1996 Jan 04; 12(1):193-200. PubMed ID: 8552392
    [Abstract] [Full Text] [Related]

  • 2. Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
    Maxwell SA, Roth JA.
    Oncogene; 1993 Dec 04; 8(12):3421-6. PubMed ID: 8247546
    [Abstract] [Full Text] [Related]

  • 3. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R, Roth JA, Maxwell SA.
    Cancer Res; 1993 Nov 15; 53(22):5361-4. PubMed ID: 8221671
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV, Das GC.
    Oncogene; 1996 Jul 18; 13(2):323-32. PubMed ID: 8710371
    [Abstract] [Full Text] [Related]

  • 9. Specific binding of MAR/SAR DNA-elements by mutant p53.
    Müller BF, Paulsen D, Deppert W.
    Oncogene; 1996 May 02; 12(9):1941-52. PubMed ID: 8649855
    [Abstract] [Full Text] [Related]

  • 10. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P, Milner J.
    Cancer Res; 1993 Oct 01; 53(19):4469-73. PubMed ID: 8402615
    [Abstract] [Full Text] [Related]

  • 11. Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.
    Tarunina M, Jenkins JR.
    Oncogene; 1993 Nov 01; 8(11):3165-73. PubMed ID: 8414520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
    Brazda V, Muller P, Brozkova K, Vojtesek B.
    Biochem Biophys Res Commun; 2006 Dec 15; 351(2):499-506. PubMed ID: 17070499
    [Abstract] [Full Text] [Related]

  • 14. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
    Iwabuchi K, Li B, Bartel P, Fields S.
    Oncogene; 1993 Jun 15; 8(6):1693-6. PubMed ID: 8502489
    [Abstract] [Full Text] [Related]

  • 15. Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.
    Ishimaru D, Ano Bom AP, Lima LM, Quesado PA, Oyama MF, de Moura Gallo CV, Cordeiro Y, Silva JL.
    Biochemistry; 2009 Jul 07; 48(26):6126-35. PubMed ID: 19505151
    [Abstract] [Full Text] [Related]

  • 16. New insights into p53 function from structural studies.
    Arrowsmith CH, Morin P.
    Oncogene; 1996 Apr 04; 12(7):1379-85. PubMed ID: 8622853
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The DNA-binding and transcription-activation abilities of p53 are necessary but not sufficient for its antiproliferation function.
    Zhang W, Randhawa GS, Guo XY, Deisseroth AB.
    Cell Growth Differ; 1994 Jul 04; 5(7):705-10. PubMed ID: 7947385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A, Resnick MA.
    Oncogene; 2001 Jun 07; 20(26):3409-19. PubMed ID: 11423991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.